Biomarkers in Pemphigus Vulgaris: A Systematic Review.
Ryan S Q GengBethany WilkenSiddhartha SoodRonald G SibbaldCathryn SibbaldPublished in: Journal of cutaneous medicine and surgery (2024)
activity, and production of anti-Dsg1/3 autoantibodies being observed. Targeting of IL-4 and IL-6 may provide therapeutic benefit. However, more research is required to validate biomarkers for clinical utility and assess viability as therapeutic targets.